The subtype was not specified, as the diagnosis was based on enzyme activity (demonstrated reduced PhK activity) rather than genetics, making this a clinically valuable presentation for the differential diagnosis of infantile hypertrophic cardiomyopathy. This evidence concerns the gene PHKA2 and hypertrophic cardiomyopathy.